Is a Pharmacologic Treatment for Neurofibromatosis Type 1 Skin Tumors on the Horizon?
Current treatment for neurofibromatosis type 1 skin tumors involves monitoring the tumors and removing them surgically if necessary, but this isn’t ideal as neurofibromas can grow back and continue originating in other parts of the body, plus surgery leaves scars. Now, scientists have identified a key player in the protein signature: the GPR68 receptor. When it is activated […]